JP2010285434A5 - - Google Patents

Download PDF

Info

Publication number
JP2010285434A5
JP2010285434A5 JP2010142292A JP2010142292A JP2010285434A5 JP 2010285434 A5 JP2010285434 A5 JP 2010285434A5 JP 2010142292 A JP2010142292 A JP 2010142292A JP 2010142292 A JP2010142292 A JP 2010142292A JP 2010285434 A5 JP2010285434 A5 JP 2010285434A5
Authority
JP
Japan
Prior art keywords
disease
use according
retinopathy
vascular
mammal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010142292A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010285434A (ja
JP5385219B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2010285434A publication Critical patent/JP2010285434A/ja
Publication of JP2010285434A5 publication Critical patent/JP2010285434A5/ja
Application granted granted Critical
Publication of JP5385219B2 publication Critical patent/JP5385219B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2010142292A 2002-07-25 2010-06-23 造血幹細胞及び該細胞を使用して眼の新生血管の疾患を治療する方法 Expired - Fee Related JP5385219B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US39852202P 2002-07-25 2002-07-25
US60/398,522 2002-07-25
US46705103P 2003-05-02 2003-05-02
US60/467,051 2003-05-02

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2005505648A Division JP2005538742A (ja) 2002-07-25 2003-07-25 造血幹細胞及び該細胞を使用して眼の新生血管の疾患を治療する方法

Publications (3)

Publication Number Publication Date
JP2010285434A JP2010285434A (ja) 2010-12-24
JP2010285434A5 true JP2010285434A5 (enExample) 2011-10-13
JP5385219B2 JP5385219B2 (ja) 2014-01-08

Family

ID=31191212

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2005505648A Pending JP2005538742A (ja) 2002-07-25 2003-07-25 造血幹細胞及び該細胞を使用して眼の新生血管の疾患を治療する方法
JP2010142292A Expired - Fee Related JP5385219B2 (ja) 2002-07-25 2010-06-23 造血幹細胞及び該細胞を使用して眼の新生血管の疾患を治療する方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2005505648A Pending JP2005538742A (ja) 2002-07-25 2003-07-25 造血幹細胞及び該細胞を使用して眼の新生血管の疾患を治療する方法

Country Status (17)

Country Link
US (2) US7153501B2 (enExample)
EP (1) EP1542536B1 (enExample)
JP (2) JP2005538742A (enExample)
KR (2) KR101095287B1 (enExample)
CN (1) CN1307300C (enExample)
AT (1) ATE536405T1 (enExample)
AU (1) AU2003259687B2 (enExample)
BR (1) BR0312920A (enExample)
CA (1) CA2493122C (enExample)
DK (1) DK1542536T3 (enExample)
ES (1) ES2376866T3 (enExample)
MX (1) MXPA05000972A (enExample)
PL (1) PL216193B1 (enExample)
PT (1) PT1542536E (enExample)
RU (1) RU2331669C2 (enExample)
WO (2) WO2004010959A2 (enExample)
ZA (1) ZA200500682B (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006031467A2 (en) * 2002-07-25 2006-03-23 The Scripps Research Institute Isolated lineage negative hematopoietic stem cells and methods of treatment therewith
US20060104963A1 (en) * 2002-07-25 2006-05-18 The Scripps Research Institute Treatment of cone cell degeneration with transfected lineage negative hematopoietic stem cells
US20060104962A1 (en) * 2002-07-25 2006-05-18 The Scripps Research Institute Transfected hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith
CA2524063C (en) * 2003-05-02 2015-02-17 The Scripps Research Institute Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith
US8088585B2 (en) * 2003-10-31 2012-01-03 Children's Medical Center Corporation Methods for purifying hematopoietic stem cells
RU2279886C2 (ru) * 2004-06-10 2006-07-20 Московский научно-исследовательский институт глазных болезней им. Гельмгольца Минздрава РФ Способ улучшения функциональной активности сетчатки при ее патологии различного генеза
US8282921B2 (en) 2004-08-02 2012-10-09 Paul Glidden tRNA synthetase fragments
JP2008509678A (ja) * 2004-08-13 2008-04-03 メドトロニック・インコーポレーテッド 内皮前駆細胞サブセットの単離とそれらの使用方法
EP1802199A4 (en) * 2004-09-03 2008-08-27 Scripps Research Inst HEMATOPOIETIC STEM CELLS OF ISOLATED NEGATIVE LINES AND METHODS OF TREATMENT THEREOF
DE102004055615A1 (de) * 2004-11-16 2006-05-18 Universitätsklinikum Hamburg-Eppendorf In vitro aus Knochenmarkstammzellen differenzierte Retina-spezifische Zellen, ihre Herstellung und Verwendung
US20080193435A1 (en) * 2005-02-24 2008-08-14 Martin Friedlander Revascularization of Ischemic Retinal Tissue and Screening Method Therefor
RU2403906C2 (ru) * 2005-02-24 2010-11-20 Дзе Скриппс Рисерч Инститьют Способ лечения ретинопатии при недоношенности и родственных ретинопатических заболеваний
RU2418856C2 (ru) * 2005-02-24 2011-05-20 Дзе Скриппс Рисерч Инститьют Изолированные популяции миелоидоподобных клеток костного мозга и способы лечения с ними
US20070231306A1 (en) * 2005-02-24 2007-10-04 The Scripps Research Institute Isolated myeloid-like cell populations and methods of treatment therewith
JP4734636B2 (ja) * 2005-11-02 2011-07-27 国立大学法人 鹿児島大学 免疫染色法、及び当該免疫染色法を利用した細胞の評価方法
US8637005B2 (en) 2005-11-07 2014-01-28 Amorcyte, Inc. Compositions and methods of vascular injury repair
WO2007055905A2 (en) 2005-11-07 2007-05-18 Amorcyte, Inc. Compositions and methods of vascular injury repair
US20110076255A1 (en) 2005-11-07 2011-03-31 Pecora Andrew L Compositions and methods for treating progressive myocardial injury due to a vascular insufficiency
GEP20135796B (en) 2006-03-07 2013-04-10 Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation
KR100757265B1 (ko) * 2006-04-27 2007-09-10 (주) 차바이오텍 제대혈 유래 줄기 세포를 포함하는 요실금 치료용 조성물
AU2007272313B2 (en) * 2006-07-12 2013-11-21 Mesoblast, Inc. Treatment of excessive neovascularization
CN101583367B (zh) * 2006-11-07 2013-05-01 夏尔再生医学公司 用于治疗和控制血管生成介导的疾病的材料和方法
US20100098675A1 (en) * 2008-05-30 2010-04-22 Nikolai Tankovich Methods for reducing the side effects of ophthalmic laser surgery
CA2737193A1 (en) * 2008-09-12 2010-03-18 Universidade Federal De Sao Paulo - Unifesp Ischemic tissue cell therapy
BRPI0920976A2 (pt) 2008-12-03 2015-08-18 Amorcyte Inc Composições que melhoram a perfusão da area de infarto e metodos de restauração da lesão vascular.
RU2428956C2 (ru) * 2009-07-13 2011-09-20 Александр Дмитриевич Ромащенко Способ лечения атрофии зрительного нерва посредством трансплантации аутологичных стволовых клеток
WO2012005763A1 (en) 2010-07-06 2012-01-12 The Scripps Research Institute Use of myeloid-like progenitor cell populations to treat tumors
CN110777124A (zh) 2011-10-27 2020-02-11 威尔斯达眼科制剂公司 编码视杆细胞来源的视锥细胞活力因子的载体
WO2013158258A1 (en) * 2012-04-16 2013-10-24 The Regents Of The University Of California Ocular therapeutics using embryonic system cell microvesicles
US11033586B2 (en) 2012-08-24 2021-06-15 Riken Method for producing retinal pigment epithelial cell sheet
CN113498347B (zh) * 2019-02-28 2024-02-02 深圳大学 内皮祖细胞(epc)在治疗早衰综合症疾病的用途
CN121550400B (zh) * 2026-01-26 2026-05-19 天津医科大学眼科医院 Crybb2重组蛋白在治疗和/或预防糖尿病性视网膜病变中的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA27055C2 (uk) * 1993-12-14 2000-02-28 Центр Ембріональних Тканин "Емселл" Лікарський препарат імуhозаміhhої дії hа осhові клітиhhої суспеhзії та спосіб лікуваhhя сиhдрому hабутого імуhодефіциту (віл-іhфекції) з використаhhям цього препарату
US6908763B1 (en) * 1997-08-22 2005-06-21 The Board Of Trustees Of The Leland Stanford Junior University Mammalian common lymphoid progenitor cell
WO1999055837A2 (en) * 1998-04-28 1999-11-04 Nycomed Imaging As Improvements in or relating to separation processes
US6767737B1 (en) * 1998-08-31 2004-07-27 New York University Stem cells bearing an FGF receptor on the cell surface
US6780627B1 (en) * 2000-01-31 2004-08-24 Millennium Pharmaceuticals, Inc. 22438, 23553, 25278, and 26212 novel human sulfatases
WO2002009650A2 (en) * 2000-07-31 2002-02-07 New York Medical College Methods and compositions for the repair and/or regeneration of damaged myocardium
CN100486992C (zh) * 2001-02-23 2009-05-13 斯克里普斯研究学院 用于调节血管发生的色氨酰-tRNA合成酶衍生的多肽
WO2003080116A1 (en) * 2002-03-21 2003-10-02 University Of Florida Modulating angiogenesis
WO2004005531A2 (en) * 2002-07-05 2004-01-15 Roger Williams Medical Center Targeting and tracking of cells to specific organs and tissues in vivo

Similar Documents

Publication Publication Date Title
Brunette et al. Alternatives to eye bank native tissue for corneal stromal replacement
Delplace et al. Delivery strategies for treatment of age-related ocular diseases: From a biological understanding to biomaterial solutions
PH12019500423A1 (en) Pharmaceutical composition
Sahle et al. Nanotechnology in regenerative ophthalmology
JP2015096556A5 (enExample)
AU2017234378B2 (en) Colony forming medium and use thereof
Ciccocioppo et al. Regenerative medicine: the red planet for clinicians
Bray et al. Immunosuppressive properties of mesenchymal stromal cell cultures derived from the limbus of human and rabbit corneas
EA201170551A1 (ru) Способы лечения заболеваний глаз
JP6141997B2 (ja) 哺乳類の幹細胞に作用する方法と、哺乳類の幹細胞に作用する薬物の応用において調製、使用される二酸化塩素
MX361520B (es) Composiciones y métodos para tratar edema ocular, neovascularización y enfermedades relacionadas.
TW201138791A (en) Angiogenesis using placental stem cells
WO2010130418A3 (en) Treatment of eye diseases using encapsulated cells encoding and secreting a neuroprotective factor and/or an anti-angiogenic factor
JP2013523823A (ja) 胎盤幹細胞を用いるサルコイドーシスの治療
BR112015009229A2 (pt) composição tendo como alvo a expressão de genes para plaquetas, célula tronco hematopoiética, uso da referida célula tronco e método in vitro ou ex vivo para gerar uma célula tronco modificada
CA2940691C (en) Method for generating endothelial colony forming cell-like cells
EP1542536A4 (en) HEMATOPOETIC STEM CELLS AND METHOD FOR THE TREATMENT OF NEOVASCULAR EYE DISEASES THEREWITH
EP4534650A3 (en) Differentiation of human ips cells to human alveolar type ii via definitive endoderm
RU2011136853A (ru) Способы и композиции для лечения неоваскуляризации
MX2014006756A (es) Celulas pulmonares fetales mamiferas y uso terapeutico de las mismas.
WO2012079088A3 (en) Mimetic peptides derived from collagen type iv and their use for treating angiogenesis- and lymphangiogenesis- dependent diseases
AR113562A1 (es) Método para inhibir la angiogénesis
Ji et al. Decellularized matrix of adipose-derived mesenchymal stromal cells enhanced retinal progenitor cell proliferation via the Akt/Erk pathway and neuronal differentiation
Liu et al. Corneal stromal mesenchymal stem cells: Reconstructing a bioactive cornea and repairing the corneal limbus and stromal microenvironment
SG11201804755VA (en) Method for manufacturing tissue/organ by using blood cells